CAELYX Side Effects

7015492-1 | Erysipelas, Intertrigo, Skin Erosion
on Sep 16, 2010 Female patient from FRANCE , 61 years of age, was diagnosed with ovarian cancer and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: erysipelas, intertrigo, skin erosion. Caelyx dosage: Course 3. During the same period patient was treated with PARAPLATIN (Course 3) (View Paraplatin Review and Paraplatin Label ). Patient was hospitalized.

7014250-1 | Cardiovascular Disorder, Hypersensitivity
Patient was taking Caelyx (View Usage). Patient had the following side effects: cardiovascular disorder, hypersensitivity on Sep 16, 2010 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with breast cancer metastatic and. Caelyx dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ).

7014151-9 | Myalgia, Pancytopenia, Rash Papular, Visual Impairment
Adverse event was reported on Sep 13, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) . Location: FRANCE , 68 years of age, After Caelyx was administered, patient had the following side effects: myalgia, pancytopenia, rash papular, visual impairment. During the same period patient was treated with NAVELBINE (First Course) (View Navelbine Review and Navelbine Label ), GEMCITABINE (First Course) (View Gemcitabine Review and Gemcitabine Label ).

7014148-9 | Interstitial Lung Disease
on Sep 13, 2010 Male patient from SOUTH AFRICA , weighting 211.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Caelyx dosage: 26 Cycles. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), ZOMETA (View Zometa Review and Zometa Label ).


7007462-4 | Dyspnoea, Pyrexia, Respiratory Tract Inflammation
on Sep 09, 2010 Female patient from NETHERLANDS , weighting 194.0 lb, was diagnosed with breast cancer recurrent and was treated with Caelyx (View Usage). Patient had the following side effects: dyspnoea, pyrexia, respiratory tract inflammation. Caelyx dosage: Four Weeks. During the same period patient was treated with XELODA (Four Weeks) (View Xeloda Review and Xeloda Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), SINTROM (View Sintrom Review and Sintrom Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DORMICUM (View Dormicum Review and Dormicum Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

7006961-9 | Dermatitis Bullous, Erythema, Palmar-plantar Erythrodysaesthesia Syndrome
Patient was taking Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: dermatitis bullous, erythema, palmar-plantar erythrodysaesthesia syndrome on Sep 10, 2010 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Caelyx dosage: . Patient was hospitalized.

7006960-7 | Tumour Marker Increased
Adverse event was reported on Sep 10, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: Two Cycles) was diagnosed with malignant peritoneal neoplasm, ovarian cancer and. Location: BRAZIL , 39 years of age, Patient experienced the following unwanted or unexpected effects: tumour marker increased.

6994455-6 | Breast Cancer, Dyspnoea, Malaise, Malignant Neoplasm Progression, Nausea
on Sep 07, 2010 Female patient from NETHERLANDS , weighting 207.2 lb, was diagnosed with breast cancer metastatic and was treated with Caelyx (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), dyspnoea, malaise, malignant neoplasm progression, nausea (What is nausea?). Caelyx dosage: . During the same period patient was treated with MOVICOLON (View Movicolon Review and Movicolon Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCICHEW (500/400 Dose) (View Calcichew Review and Calcichew Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6975623-6 | Interstitial Lung Disease
on Sep 01, 2010 Male patient from SOUTH AFRICA , 57 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: interstitial lung disease. Caelyx dosage: 26 Cycles. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ).

6961179-0 | Breast Cancer Metastatic, Cellulitis
Patient was taking Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer metastatic, cellulitis (What is cellulitis?) on Aug 23, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 156.5 lb, was diagnosed with breast cancer metastatic and. Caelyx dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), FURADANTIN (View Furadantin Review and Furadantin Label ). Patient was hospitalized.

6927481-3 | Areflexia, Ataxia, Balance Disorder, Cough, Cytomegalovirus Chorioretinitis, Cytomegalovirus Infection, Diarrhoea, Dyspnoea Exertional, Eschar
Adverse event was reported on Aug 06, 2010 by a Male patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with plasmablastic lymphoma, hiv infection (What is hiv infection?), prophylaxis and. Location: UNITED KINGDOM , 50 years of age, Patient had the following side effects: areflexia, ataxia (What is ataxia?), balance disorder, cough, cytomegalovirus chorioretinitis, cytomegalovirus infection (What is cytomegalovirus infection?), diarrhoea, dyspnoea exertional, eschar. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6906622-8 | Tremor
on Jul 28, 2010 Female patient from SPAIN , 72 years of age, was diagnosed with endometrial cancer and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: tremor. Caelyx dosage: .

6900602-4 | Myocardial Infarction
on Jul 23, 2010 Female patient from MALAYSIA , 58 years of age, was diagnosed with ovarian cancer metastatic and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Caelyx dosage: .

6899967-1 | Areflexia, Ataxia, Balance Disorder, Cough, Cytomegalovirus Chorioretinitis, Cytomegalovirus Infection, Diarrhoea, Dyspnoea Exertional, Eschar
Patient was taking Caelyx (View Usage). Patient had the following side effects: areflexia, ataxia (What is ataxia?), balance disorder, cough, cytomegalovirus chorioretinitis, cytomegalovirus infection (What is cytomegalovirus infection?), diarrhoea, dyspnoea exertional, eschar on Jul 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, was diagnosed with plasmablastic lymphoma, hiv infection (What is hiv infection?), prophylaxis and. Caelyx dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6895132-2 | Colitis Ischaemic
Adverse event was reported on Jul 22, 2010 by a Male patient taking Caelyx (View Usage) (Dosage: Cycle 2) was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?) and. Location: FRANCE , 50 years of age, After Caelyx was administered, patient had the following side effects: colitis ischaemic. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), AMLOR (View Amlor Review and Amlor Label ). Patient was hospitalized.

6886980-3 | Electrocardiogram Abnormal, Infusion Related Reaction
on Jul 21, 2010 Female patient from GERMANY , 39 years of age, was diagnosed with breast cancer metastatic and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram abnormal, infusion related reaction. Caelyx dosage: . During the same period patient was treated with NAVOBAN (View Navoban Review and Navoban Label ), CORTISONE (View Cortisone Review and Cortisone Label ), EMEND (View Emend Review and Emend Label ).

6875603-5 | Areflexia, Ataxia, Balance Disorder, Cough, Cytomegalovirus Chorioretinitis, Cytomegalovirus Infection, Diarrhoea, Dyspnoea Exertional, Eschar
on Jul 15, 2010 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with plasmablastic lymphoma, prophylaxis, hiv infection (What is hiv infection?) and was treated with Caelyx (View Usage). Patient had the following side effects: areflexia, ataxia (What is ataxia?), balance disorder, cough, cytomegalovirus chorioretinitis, cytomegalovirus infection (What is cytomegalovirus infection?), diarrhoea, dyspnoea exertional, eschar. Caelyx dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), COTRIM (View Cotrim Review and Cotrim Label ), DARUNAVIR ETHANOLATE (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ). Patient was hospitalized.

6866090-1 | Myocardial Infarction
Patient was taking Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: myocardial infarction on Jul 19, 2010 from MALAYSIA Additional patient health information: Female patient , 58 years of age, was diagnosed with ovarian cancer metastatic and. Caelyx dosage: .

6847427-6 | Electrocardiogram Abnormal, Infusion Related Reaction
Adverse event was reported on Jul 07, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: GERMANY , 39 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram abnormal, infusion related reaction.

6847426-4 | Interstitial Lung Disease
on Jul 07, 2010 Female patient from FRANCE , 75 years of age, weighting 127.9 lb, was diagnosed with ovarian epithelial cancer and was treated with Caelyx (View Usage). Patient had the following side effects: interstitial lung disease. Caelyx dosage: .

6801034-X | Bronchospasm, Infusion Related Reaction, Off Label Use, Respiratory Arrest, Urethral Cancer
on Jun 23, 2010 Female patient from BELGIUM , 61 years of age, was diagnosed with urethral cancer, deep vein thrombosis (What is deep vein thrombosis?), reflux oesophagitis and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: bronchospasm, infusion related reaction, off label use, respiratory arrest, urethral cancer. Caelyx dosage: . During the same period patient was treated with INNOHEP (View Innohep Review and Innohep Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6782946-2 | Anxiety, Chest Discomfort, Tachycardia
Patient was taking Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chest discomfort, tachycardia on May 21, 2010 from MALAYSIA Additional patient health information: Female patient , 41 years of age, . Caelyx dosage: . During the same period patient was treated with CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), TROPISETRON (View Tropisetron Review and Tropisetron Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6778865-8 | Flushing, Hypotension, Infusion Related Reaction, Off Label Use, Wheezing
Adverse event was reported on Jun 09, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with neoplasm malignant, sarcoma and. Location: UNITED KINGDOM , 48 years of age, Patient had the following side effects: flushing, hypotension, infusion related reaction, off label use, wheezing. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6751847-8 | Neutropenia, Relapsing Fever, Thrombocytopenia
on May 23, 2010 Female patient from SWITZERLAND , 52 years of age, was diagnosed with ovarian cancer and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: neutropenia, relapsing fever, thrombocytopenia. Caelyx dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6743074-5 | Infusion Related Reaction, Laryngeal Oedema, Off Label Use, Rash, Respiratory Failure
on May 17, 2010 Male patient from MEXICO , child 11 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, laryngeal oedema, off label use, rash (What is rash?), respiratory failure. Caelyx dosage: . During the same period patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6742006-3 | Infusion Related Reaction, Laryngeal Oedema, Off Label Use, Rash, Respiratory Failure
Patient was taking Caelyx (View Usage). Patient had the following side effects: infusion related reaction, laryngeal oedema, off label use, rash (What is rash?), respiratory failure on May 17, 2010 from MEXICO Additional patient health information: Male patient , 16 years of age, was diagnosed with hodgkin's disease stage iii and. Caelyx dosage: . During the same period patient was treated with DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6737389-4 | Off Label Use, Respiratory Failure
Adverse event was reported on May 11, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) . Location: MEXICO , child 8 years of age, After Caelyx was administered, patient had the following side effects: off label use, respiratory failure.

6735135-1 | Breast Cancer, Hepatic Fibrosis
on May 13, 2010 Female patient from SPAIN , 50 years of age, was diagnosed with breast cancer metastatic and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), hepatic fibrosis. Caelyx dosage: .

6735073-4 | Infusion Related Reaction, Off Label Use, Respiratory Failure
on May 11, 2010 Female patient from MEXICO , 13 years of age, was treated with Caelyx (View Usage). Patient had the following side effects: infusion related reaction, off label use, respiratory failure. Caelyx dosage: .

6735060-6 | Adverse Event, Infusion Related Reaction, Off Label Use
Patient was taking Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: adverse event, infusion related reaction, off label use on May 11, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 48 years of age, . Caelyx dosage: .

6733828-3 | Flushing, Hypertensive Crisis, Infusion Related Reaction, Sense Of Oppression
Adverse event was reported on May 11, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with ovarian cancer metastatic and. Location: ITALY , 70 years of age, Patient experienced the following unwanted or unexpected effects: flushing, hypertensive crisis, infusion related reaction, sense of oppression.

6733274-2 | Cyanosis, Erythema, Infusion Related Reaction, Off Label Use, Respiratory Failure
on May 11, 2010 Female patient from MEXICO , child 3 years of age, was treated with Caelyx (View Usage). Patient had the following side effects: cyanosis, erythema, infusion related reaction, off label use, respiratory failure. Caelyx dosage: .

6714991-7 | Oedema Peripheral, Pyrexia
on Apr 28, 2010 Female patient from FINLAND , 63 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: oedema peripheral, pyrexia. Caelyx dosage: . During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6713557-2 | Off Label Use, Respiratory Failure
Patient was taking Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, respiratory failure on Apr 26, 2010 from MEXICO Additional patient health information: Male patient , 20 years of age, was diagnosed with non-hodgkin's lymphoma and. Caelyx dosage: Second Dose. Patient was hospitalized.

6711422-8 | Bronchospasm, Respiratory Arrest
Adverse event was reported on Apr 29, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) . Location: BELGIUM , 61 years of age, Patient had the following side effects: bronchospasm, respiratory arrest. Patient was hospitalized.

6701996-5 | Circulatory Collapse, Infusion Related Reaction, Loss Of Consciousness
on Apr 23, 2010 Female patient from GERMANY , 73 years of age, weighting 255.7 lb, was diagnosed with breast cancer metastatic and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: circulatory collapse, infusion related reaction, loss of consciousness. Caelyx dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LASIX (View Lasix Review and Lasix Label ), KEVATRIL (View Kevatril Review and Kevatril Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6660570-X | Neutropenia, Renal Impairment
on Mar 19, 2010 Male patient from UNITED KINGDOM , 17 years of age, was diagnosed with burkitt's lymphoma, prophylaxis and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, renal impairment. Caelyx dosage: 200mg/m2 Cumulative Dose. During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), THIOGUANINE (750 Mg/m2 Cumulative Dose) (View Thioguanine Review and Thioguanine Label ), ARA C (1000 Mg/m2 Cumulative Dose) (View Ara-c Review and Ara-c Label ), METHOTREXATE (4g/m2 Cumulative Dose) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (2g/m2 Cumulative Dose) (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (1500 Mg Sumulative Dose) (View Rituximab Review and Rituximab Label ), VINCRISTINE (6 Mg/m2 Cumulative Dose) (View Vincristine Review and Vincristine Label ), VP 16 (400 Mg/m2 Cumulative Dose) (View Vp-16 Review and Vp-16 Label ).

6657934-7 | Hepatitis B
Patient was taking Caelyx (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?) on Mar 16, 2010 from ITALY Additional patient health information: Female patient , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Caelyx dosage: . During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ).

6649099-2 | Muscular Weakness, Myalgia, Neuralgia, Neuropathy Peripheral
Adverse event was reported on Feb 23, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: GREECE , weighting 211.6 lb, After Caelyx was administered, patient had the following side effects: muscular weakness, myalgia, neuralgia, neuropathy peripheral. During the same period patient was treated with VELCADE (Days 1,4,8,11 Of Cycle) (View Velcade Review and Velcade Label ), DEXAMETHASONE (Days 1-4, 9-12, 17-20 Of Cycle) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6648109-6 | Acute Hepatic Failure, Cardiopulmonary Failure, Hepatic Encephalopathy, Hepatitis B, Hepatitis Fulminant, Off Label Use, Renal Failure
on Mar 16, 2010 Male patient from POLAND , 27 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, cardiopulmonary failure, hepatic encephalopathy, hepatitis b (What is hepatitis b?), hepatitis fulminant, off label use, renal failure. Caelyx dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6634152-X | Muscular Weakness, Myalgia, Neuralgia, Neuropathy Peripheral
on Mar 05, 2010 Female patient from GREECE , weighting 211.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). Patient had the following side effects: muscular weakness, myalgia, neuralgia, neuropathy peripheral. Caelyx dosage: . During the same period patient was treated with VELCADE (Days 1,4,8,11 Of Cycle) (View Velcade Review and Velcade Label ), DEXAMETHASONE (Days 1-4, 9-12, 17-20 Of Cycle) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6633872-0 | Genital Infection Fungal, Mucosal Ulceration, Palmar-plantar Erythrodysaesthesia Syndrome, Pneumonia
Patient was taking Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: genital infection fungal, mucosal ulceration, palmar-plantar erythrodysaesthesia syndrome, pneumonia (What is pneumonia?) on Mar 09, 2010 from GERMANY Additional patient health information: Female patient , 82 years of age, weighting 174.2 lb, was diagnosed with malignant peritoneal neoplasm and. Caelyx dosage: 70 /m^2.

6618443-4 | Coagulopathy, Palmar-plantar Erythrodysaesthesia Syndrome, Pancytopenia, Rash, Subdural Haematoma
Adverse event was reported on Mar 02, 2010 by a Female patient taking Caelyx (View Usage) (Dosage: ) was diagnosed with ovarian cancer, breast cancer (What is breast cancer?) and. Location: GERMANY , 67 years of age, weighting 218.3 lb, Patient experienced the following unwanted or unexpected effects: coagulopathy, palmar-plantar erythrodysaesthesia syndrome, pancytopenia, rash (What is rash?), subdural haematoma. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), NOVODIGAL (View Novodigal Review and Novodigal Label ). Patient was hospitalized.

6615931-1 | Muscular Weakness, Myalgia, Neuralgia, Neuropathy Peripheral
on Feb 23, 2010 Female patient from SWITZERLAND , weighting 211.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). Patient had the following side effects: muscular weakness, myalgia, neuralgia, neuropathy peripheral. Caelyx dosage: . During the same period patient was treated with VELCADE (Days 1,4,8,11 Of Cycle) (View Velcade Review and Velcade Label ), DEXAMETHASONE (Days 1-4, 9-12, 17-20 Of Cycle) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6604838-1 | Hepatic Encephalopathy, Hepatitis B, Hepatitis Fulminant, Off Label Use, Renal Failure
on Feb 23, 2010 Male patient from POLAND , 27 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: hepatic encephalopathy, hepatitis b (What is hepatitis b?), hepatitis fulminant, off label use, renal failure. Caelyx dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6601899-0 | Neutropenia, Renal Impairment
Patient was taking Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, renal impairment on Feb 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 17 years of age, was diagnosed with burkitt's lymphoma, prophylaxis and. Caelyx dosage: . During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXRAZOXANE (View Dexrazoxane Review and Dexrazoxane Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (2g/m2) (View Prednisolone Review and Prednisolone Label ).

6601897-7 | Neutropenia, Renal Impairment
Adverse event was reported on Feb 16, 2010 by a Male patient taking Caelyx (View Usage) (Dosage: 200mg/m2 Cumulative Dose) was diagnosed with burkitt's lymphoma, prophylaxis and. Location: UNITED KINGDOM , 17 years of age, Patient had the following side effects: neutropenia, renal impairment. During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), THIOGUANINE (750 Mg/m2 Cumulative Dose) (View Thioguanine Review and Thioguanine Label ), ARA C (1000 Mg/m2 Cumulative Dose) (View Ara-c Review and Ara-c Label ), METHOTREXATE (4g/m2 Cumulative Dose) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (2g/m2 Cumulative Dose) (View Prednisolone Review and Prednisolone Label ), RITUXIMAB (1500 Mg Sumulative Dose) (View Rituximab Review and Rituximab Label ), VINCRISTINE (6 Mg/m2 Cumulative Dose) (View Vincristine Review and Vincristine Label ), VP 16 (400 Mg/m2 Cumulative Dose) (View Vp-16 Review and Vp-16 Label ).

6600997-5 | Haemolytic Anaemia
on Feb 16, 2010 Female patient from NORWAY , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Caelyx (View Usage). After Caelyx was administered, patient had the following side effects: haemolytic anaemia. Caelyx dosage: . Patient was hospitalized.

6587622-7 | Cerebral Haemorrhage, Intracranial Aneurysm
on Feb 05, 2010 Male patient from ITALY , 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Caelyx (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, intracranial aneurysm. Caelyx dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6585827-2 | Hepatic Fibrosis
Patient was taking Caelyx (View Usage). Patient had the following side effects: hepatic fibrosis on Feb 05, 2010 from SPAIN Additional patient health information: Female patient , 50 years of age, was diagnosed with breast cancer metastatic and. Caelyx dosage: .